Mostrar el registro sencillo del ítem

Artículo

dc.creatorLosa, F.es
dc.creatorIglesias, L.es
dc.creatorPane, M.es
dc.creatorSanz, J.es
dc.creatorNieto, B.es
dc.creatorFuste, V.es
dc.creatorCruz Merino, Luis de laes
dc.creatorConcha, A.es
dc.creatorBalana, C.es
dc.creatorMatias-Guiu, X.es
dc.date.accessioned2024-03-11T15:23:51Z
dc.date.available2024-03-11T15:23:51Z
dc.date.issued2018
dc.identifier.citationLosa, F., Iglesias, L., Pane, M., Sanz, J., Nieto, B., Fuste, V.,...,Matias-Guiu, X. (2018). 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary. Clinical and Translational Oncology, 20 (11), 1361-1372. https://doi.org/10.1007/s12094-018-1899-z.
dc.identifier.issn1699-048Xes
dc.identifier.issn1699-3055es
dc.identifier.urihttps://hdl.handle.net/11441/156107
dc.description.abstractCancer of unknown primary (CUP) is defned as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They difer from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2–9% of all cancer patients, mostly 60–75 years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP.The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed.es
dc.formatapplication/pdfes
dc.format.extent12 p.es
dc.language.isoenges
dc.publisherSpringeres
dc.relation.ispartofClinical and Translational Oncology, 20 (11), 1361-1372.
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCancer of unknown primaryes
dc.subjectDiagnosises
dc.subjectImmunohistochemistryes
dc.subjectBiopsyes
dc.subjectPrognosises
dc.subjectChemotherapyes
dc.subjectMolecular pathologyes
dc.subjectHistopathologyes
dc.title2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primaryes
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s12094-018-1899-zes
dc.identifier.doi10.1007/s12094-018-1899-zes
dc.contributor.groupUniversidad de Sevilla. CTS151: Bioquímica médica.es
dc.journaltitleClinical and Translational Oncologyes
dc.publication.volumen20es
dc.publication.issue11es
dc.publication.initialPage1361es
dc.publication.endPage1372es

FicherosTamañoFormatoVerDescripción
2018 consensus statement.pdf1.125MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional